WebMD: How is FDA getting clinical trials to be more diverse?

WebMD interview with FDA's Dr. Jonca Bull and Dr. John Whyte

Your age, sex, and race may influence how your body responds to certain medications, but most people studied in clinical trials are white and male. WebMD talked about FDA's efforts to increase diversity in clinical trials with two FDA officials:

Jonca Bull, MDAssistant Commissioner, FDA Office of Minority Health

John Whyte, MD, MPH
Director of Professional Affairs and Stakeholder Engagement,
FDA Center for Drug Evaluation and Research